NCT02841449

Brief Summary

The aim of this study is to investigate whether hydration status affects blood sugar control and appetite regulation. In order to do this, participants will undergo a monitoring phase whereby their weight, diet and physical activity are monitored, followed by a dehydration protocol involving fluid restriction and sitting in a heat tent. In one arm of the trial, participants will remain dehydrated for the remainder of the day (i.e. after the heat tent) by having their fluid intake restricted, and in the other arm of the trial, participants will be rehydrated by consuming the necessary amount of plain water. All participants will undergo both arms of the trial, the order of which will be chosen randomly. Several measures will be taken throughout the trial. Before participants go into the heat tent, they will provide a urine sample (for baseline hydration status as indicated by urine osmolality), a blood sample (for glucose, insulin, arginine vasopressin,/copeptin, ghrelin and serum osmolality and plasma volume), and have a peripheral quantitative computer tomography scan of their thigh to indicate muscle size. On the day proceeding the heat tent, participants will have these measures repeated, along with metabolic rate before consuming a 75 g glucose drink, followed by 15 minutely blood samples and hourly metabolic rate measures for 120 minutes (i.e. an oral glucose tolerance test; OGTT). Following this, participants will be presented with a large bowl of pasta and sauce and will be instructed to eat until satisfied (maximum 30 min). Blood samples will be taken every 10 minutes for 60 minutes following the meal. Participants also have the option to opt-in to have a muscle biopsy taken. This will be taken before and \~120 minutes after the glucose drink.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Jul 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

July 7, 2016

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 22, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
3.5 years until next milestone

Results Posted

Study results publicly available

June 22, 2020

Completed
Last Updated

June 22, 2020

Status Verified

June 1, 2020

Enrollment Period

6 months

First QC Date

July 7, 2016

Results QC Date

March 7, 2020

Last Update Submit

June 18, 2020

Conditions

Keywords

HydrationGlycemic controlAppetiteEndocrinology

Outcome Measures

Primary Outcomes (1)

  • Glycemic Response

    Primary analysis is time trends (i.e. ANOVA effects), supported by indices of the glycemic response (e.g. iAUC, time to peak). Blood was taken pre-muscle biopsy (if participants opted in for a muscle biopsy), before consuming the glucose drink (after the biopsy, where applicable), then at 15 minutely samples for 120 minutes. After the meal test, blood was drawn at 10 minutely intervals for 60 minutes, starting 30 minutes after commencement of eating.

    Measured on day 5 on both trial arms, using the blood sample drawn before the glucose beverage is consumed and the blood samples drawn for the subsequent 120 minutes

Secondary Outcomes (8)

  • Insulinemic Response

    Measured on day 5 on both trial arms, using the blood sample drawn before the glucose beverage is consumed and the blood samples drawn for the subsequent 120 minutes

  • Arginine Vasopressin and Copeptin Response

    Measured on day 5 on both trial arms, using the blood sample drawn before the glucose beverage is consumed and the blood samples drawn for the subsequent 120 minutes (please note: may measure copeptin as a marker of arginine vasopressin)

  • Ghrelin Response

    Measured on day 5 on both trial arms, using the blood sample drawn before the participant starts eating the buffet and the subsequent post-buffet blood samples

  • Energy Intake

    Measured on day 5 on both trial arms from the pasta test meal

  • Metabolic Rate

    Using the metabolic rate data collected on day 5 on both trial arms

  • +3 more secondary outcomes

Other Outcomes (5)

  • Serum Osmolality

    Measured from the blood samples on day 4 and day 5 on both trial arms

  • Plasma Volume

    Measured from the blood samples on day 4 and day 5 on both trial arms

  • Other Metabolites

    Collected from the blood samples throughout day 5 of both trial arms

  • +2 more other outcomes

Study Arms (2)

Hypohydrated

EXPERIMENTAL

After being dehydrated in the heat tent, participants in this trial arm will be given 3 mL/kg lean body mass to consume over the rest of the day (e.g. a 75 kg participant with a body composition of 85 % fat free mass would consume 191 mL water \[63.75 kg \* 3 mL\])

Behavioral: Hypohydrated

Rehydrated

EXPERIMENTAL

After being dehydrated in the heat tent, participants in this trial arm will be given 40 mL/kg lean body mass plus 150 % of their water losses (from the heat tent procedure) over the rest of the day (e.g. a 75 kg participant with a body composition of 85 % fat free mass and lost 1 % of their body mass in the heat tent (0.75 kg) would consume 2550 mL \[63.75 kg \* 40 mL\] + 1125 mL \[750 g \* 1.5\], totalling 3675 mL).

Behavioral: Rehydrated

Interventions

HypohydratedBEHAVIORAL

Participants remain hypohydrated after the heat tent procedure

Hypohydrated
RehydratedBEHAVIORAL

Participants rehydrate after the heat tent procedure

Rehydrated

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy male or female
  • Aged 18-60 years
  • Able and willing to give informed consent

You may not qualify if:

  • Any known metabolic or glucose disorder
  • Taking necessary medication (other than contraceptives) or supplements that are known to affect glycaemic control (e.g. chromium, PUFAs)
  • Current alcohol or drug dependency
  • Aged \< 18 years, or \> 60 years; pregnant or breastfeeding
  • Any other factors which are deemed to have the potential to cause harm to the participant and/or could introduce bias into the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Bath

Bath, Somerset, BA2 7AY, United Kingdom

Location

Related Publications (4)

  • Taveau C, Chollet C, Waeckel L, Desposito D, Bichet DG, Arthus MF, Magnan C, Philippe E, Paradis V, Foufelle F, Hainault I, Enhorning S, Velho G, Roussel R, Bankir L, Melander O, Bouby N. Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats. Diabetologia. 2015 May;58(5):1081-90. doi: 10.1007/s00125-015-3496-9. Epub 2015 Jan 27.

    PMID: 25622862BACKGROUND
  • Roussel R, Fezeu L, Bouby N, Balkau B, Lantieri O, Alhenc-Gelas F, Marre M, Bankir L; D.E.S.I.R. Study Group. Low water intake and risk for new-onset hyperglycemia. Diabetes Care. 2011 Dec;34(12):2551-4. doi: 10.2337/dc11-0652. Epub 2011 Oct 12.

    PMID: 21994426BACKGROUND
  • Keller U, Szinnai G, Bilz S, Berneis K. Effects of changes in hydration on protein, glucose and lipid metabolism in man: impact on health. Eur J Clin Nutr. 2003 Dec;57 Suppl 2:S69-74. doi: 10.1038/sj.ejcn.1601904.

    PMID: 14681716BACKGROUND
  • Zerbe RL, Vinicor F, Robertson GL. Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes. 1979 May;28(5):503-8. doi: 10.2337/diab.28.5.503.

    PMID: 108167BACKGROUND

Results Point of Contact

Title
Dr Harriet Carroll
Organization
University of Bath

Study Officials

  • Harriet A Carroll, MRes

    University of Bath

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Student

Study Record Dates

First Submitted

July 7, 2016

First Posted

July 22, 2016

Study Start

July 1, 2016

Primary Completion

January 1, 2017

Study Completion

January 1, 2017

Last Updated

June 22, 2020

Results First Posted

June 22, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will share

Anonymised data will be shared

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
Available (no time restrictions)
Access Criteria
Open access; doi URL below for hydration-glycaemia data, related report: https://doi.org/10.1152/japplphysiol.00771.2018; data for hydration-appetite: https://doi.org/10.15125/BATH-00719 and related report: https://doi.org/10.1016/j.physbeh.2019.112725
More information

Locations